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Abstract
Background: The disease burden related to mental disorders and metabolic syndrome is growing in low-and
middle-income countries (LMIC). The Colombo Twin and Singleton Study (COTASS) is a population-based sample
of twins and singletons in Colombo, Sri Lanka. Here we present prevalence estimates for metabolic syndrome
(metS) and mental disorders from a follow-up (COTASS-2) of the original study (COTASS-1), which was a mental
health survey.
Methods: In COTASS-2, participants completed structured interviews, anthropometric measures and provided
fasting blood and urine samples. Depressive disorder, depressive symptoms, anxiety symptoms, post-traumatic
stress disorder (PTSD) and hazardous alcohol use were ascertained with structured psychiatric screens (Composite
International Diagnostic Interview (CIDI), Beck Depression Inventory (BDI-II), Generalised Anxiety Disorder
Questionnaire (GAD-7), PTSD Checklist – Civilian Version (PCL-C), and Alcohol Use Disorders Identification Test
(AUDIT)). We defined metS according to the International Diabetes Federation (IDF) criteria and the revised
National Cholesterol Education Programme Adult Treatment Panel (NCEP ATP III) criteria. We estimated the
prevalence of psychiatric disorders and metS and metS components, and associations with gender, education
and age.
Results: Two thousand nine hundred thirty-four twins and 1035 singletons were followed up from COTASS-1 (83.4
and 61.8% participation rate, respectively). Prevalence estimates for depressive disorder (CIDI), depressive symptoms
(BDI≥ 16), anxiety symptoms (GAD-7≥ 10) and PTSD (PCL-C DSM criteria) were 3.8, 5.9, 3.6, and 4.5% respectively for
twins and 3.9, 9.8, 5.1 and 5.4% for singletons. 28.1 and 30.9% of male twins and singletons respectively reported
hazardous alcohol use. Approximately one third met the metS criteria (IDF: 27.4% twins, 44.6% singletons; NCEP ATP III:
30.6% twins, 48.6% singletons). The most prevalent components were central obesity (59.2% twins, 71.2% singletons)
and raised fasting blood glucose or diabetes (38.2% twins, 56.7% singletons).
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Conclusion: MetS was highly prevalent in twins, and especially high in singletons, whereas the prevalence of mental
disorders was low, but consistent with local estimates. The high levels of raised fasting plasma glucose and central
obesity were particularly concerning, and warrant national diabetes prevention programmes.
Background
Low and middle income countries (LMIC) globally have
undergone rapid urbanisation, and changes in demog-
raphy and health behaviours [1, 2]. Whilst life expect-
ancy at birth for many LMIC has improved, disease
burden from non-communicable diseases, and years
lived with disability have risen [3, 4]. In 2012, 82% of all
global premature deaths attributable to non-
communicable diseases occurred in LMICs [2]. The glo-
bal burden of mental disorders, particularly depression,
is also forecast to rise and depression is strongly associ-
ated with many non-communicable diseases [5]. In Sri
Lanka, the setting for the present study, coronary heart
disease is the leading cause of mortality, one in ten in
the population has diabetes, and there has been an expo-
nential increase in hospitalisations due to these diseases
[6–8]. High prevalence estimates of their risk factors, in-
cluding hypertension (18–20%), dysglycaemia (14–20%)
and obesity (9–36%) have been reported [7, 9–11].
MetS represents a cluster of metabolic abnormalities
which indicate an elevated risk of future development
of type II diabetes and cardiovascular disease (CVD)
[12–17]. Its status as a syndrome, and its predictive val-
idity as a specific risk factor for type 2 diabetes and
CVD (over and above its constituent parts), are debated
and some have called into question the usefulness of
metS as a specific entity [18]. The confidence in its
nosological status could be improved if it could be
demonstrated that the clustered phenotypes are driven
by the same underlying genes. This may be tested using
multivariable behavioural genetics, which permits a bet-
ter understanding of the genetic architecture of the
syndrome would strengthen the biological plausibility
of metS. For this reason, we conducted a study of car-
diometabolic risk using a sample of twins and single-
tons in Colombo, Sri Lanka; a study design which
allows for these types of analyses.
Studying cardiometabolic risk in a South Asian popu-
lation in a genetically sensitive design is of particular
interest given suggestions that the elevated incidence of
cardiovascular disease and diabetes in South Asian pop-
ulations may be partially explained by mechanisms
involving gene-environment interactions [19]. Such her-
itable adaptations may include those which improve
resilience to prolonged periods of food shortage (the so-
called “thrifty genotype”), but at times of excess lead to
greater susceptibility of developing obesity and other
metS phenotypes [20, 21]. This may mean that metS in
South Asian populations is different in terms both of
phenotypic associations and genetic architecture com-
pared with Western populations.
This paper describes the Colombo Twin and Singleton
Follow-up Study (COTASS-2) – a population based
study of twins and singletons from the Colombo District,
Sri Lanka. COTASS-2 explores mental health and car-
diovascular risk factors, and the role of genetic and
environmental influences on their variance and covari-
ance. The specific aims of COTASS-2 were to: (1) esti-
mate the (genetic) stability of depression in a south
Asian population; (2) describe the prevalence of the
component phenotypes which make up “metS” in Sri
Lanka; (3) explore the genetic architecture of metS phe-
notypes, and estimate the extent to which phenotypic
associations are explained by shared genetic and envir-
onmental effects and (4) investigate the aetiological over-
lap between depression and the component phenotypes
of metS.
In the present paper we describe the methods of
COTASS-2 and present prevalence estimates of metS, its
components, and mental disorders, separately for twins
and singletons.
Methods
Setting
Colombo District has a population of 2.32 m, composed
of multiple ethnic groups, including Sinhalese (76.5%),
Tamils (11.2%) and Moors (10.7%). It is mainly classified
as urban (77.6%) and includes the capital city of Sri
Lanka, Colombo, but the wider district also includes
rural areas [22]. Typical of many urban regions, the dis-
trict attracts a high level of immigration, of which a sub-
stantial minority have been displaced as a result of
conflict [23]. The population is characterised by great
socio-economic diversity in terms of education, employ-
ment, and occupational social class. Since data collection
ended for the original COTASS study in 2007, the three
decade-long civil conflict in Sri Lanka came to an end.
Description of COTASS-2
COTASS-2 took place between 2012 and 2015, and is a
follow-up study of the Colombo Twin and Singleton
Study (COTASS-1), conducted in 2005–2007 [24].
COTASS-1 focussed on mental health, and achieved a
91% participation rate for a carefully ascertained
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population of twins residing in Colombo District, and an
87% participation rate for singletons recruited from the
same area. COTASS-2 consisted of three components:
an interview component, collection of anthropometric
data, and biosample (blood and urine) collection for
clinical investigations and biobanking. Two sub-studies
examining the autonomic nervous system using heart
rate variability measures, and sleep and physical activity
using actigraphy were nested within COTASS-2. The
study received ethical approval from Psychiatry, Nursing
& Midwifery Research Ethics Subcommittee, King’s Col-
lege London, UK (reference number: PNM/10/11-124),
and the Faculty of Medical Sciences University of Sri
Jayewardenepura Ethical Review Committee (USJP ERC)
(reference number: 596/11).
Participant tracing and data collection
Participant tracing and recruitment
The recruitment process of the original COTASS-1 sam-
ple is described in Siribaddana et al. [24]. In recruiting
for COTASS-2, COTASS-1 participants were sent invita-
tion letters, and trained field research assistants (FRAs)
traced participants by telephone and home visits. Writ-
ten informed consent was obtained for each study com-
ponent that they opted to partake in. Participants unable
to understand the consent process or the questionnaires
due to language barriers or apparent cognitive impair-
ments were excluded. Participants successfully complet-
ing one or more study components were offered 750
LKR (approximately £3.50 GBP) to compensate for time
and inconvenience.
Interview data collection
Fifteen FRAs were involved in recruitment and question-
naire data collection. All FRAs had at minimum high
school qualifications. They received training on basic
research methodology and research ethics; collecting
informed consent, and conducting the paper and pen
based questionnaire interviews. Interviews lasted 1–2 h
and were typically conducted in participants’ homes.
Quality checks were performed throughout data collec-
tion. Study coordinators performed random unannounced
spot checks while FRAs conducted interviews. The study
coordinators and the data entry team checked question-
naires thoroughly for errors and inconsistencies before
accepting completed questionnaire booklets. A sub-
sample of randomly selected participants were phoned to
confirm that the collected questionnaire data were accur-
ate. An experienced data entry team entered data into a
database using SPSS version 13 [25].
Interview measures
Interviews involved 19 scales and checklists measuring
sociodemographic characteristic, health and functioning
measures including structured assessments of psychiatric
disorders, health behaviours, stressful life events and social
support, and zygosity (see Additional file 1: Table S1).
Sociodemographic characteristics Sociodemographic
information was collected through adapted Sri Lankan
census measures [22], including gender, age, ethnicity,
occupation, education, household composition and
housing quality.
Health and functioning measures Structured symptom
screens measured several psychiatric disorders. Section
E of the World Health Organization’s Composite Inter-
national Diagnostic Interview (CIDI) captured probable
depression diagnoses over the past year [26], and the
Beck Depression Inventory (BDI) captured depressive
symptom severity over the past 2 weeks [27]. Post-
traumatic stress disorder and anxiety were measured
using the PTSD Checklist Civilian version [28] and the
Generalised Anxiety Disorder questionnaire [29] respect-
ively. The Bradford Somatic Inventory [30] screened for
somatic symptoms while the Chalder Fatigue Scale [31]
measured the severity and extent of fatigue. The Dutch
Eating Behaviour Questionnaire [32] and the Three-
Factor Eating Questionnaire [33] identified eating disor-
ders. The Short Form 36 Health Survey Questionnaire
[34] measured general health and wellbeing. Sleep over
the month was assessed using the Pittsburgh Sleep Qual-
ity Index [35]. A physical illness checklist, developed by
the Institute of Research and Development (IRD) Sri
Lanka, identified significant current and life-time phys-
ical illnesses (requiring medication).
Health behaviours The International Physical Activity
Questionnaire [36], an internationally validated scale,
captured exercise over the past 7 days. Dietary patterns
were measured using a culturally adapted version of the
food frequency questionnaire; revised in consultation
with local experts [37]. Tobacco and alcohol use were
measured using adapted versions of the Tobacco Use
questionnaire of the WHO STEPS Instrument [38] and
the WHO’s Alcohol Use Disorders Identification Test
(AUDIT) [39].
Stressful life events and social support Stressful life
events were measured using a culturally adapted version
of the list of threatening experiences questionnaire [40].
Social support and psychological wellbeing was mea-
sured using a modified version of the multi-dimensional
support scale questionnaire [41].
Zygosity and closeness-of-twins measures Zygosity
was ascertained in COTASS-1 using a questionnaire meas-
ure of similarity [24, 42]. If zygosity was missing in
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COTASS-1 it was replaced with zygosity information col-
lected using the same questionnaire in COTASS-2 (n = 88).
The closeness of twins within pairs was measured using
items adapted from a study which measured individual
differences in personality, ability and interests [43], and
another study on psychiatric disorders which measured
similarity of environmental experiences of twins [44].
Translation and adaptation of new scales for
COTASS-2 Many of the questionnaire components had
already been translated and validated in COTASS-1 and
other projects [24, 45]. The new scales for COTASS-2
were translated by a panel consisting of Sri Lankan
health professionals, academics, and a scholar fluent in
both Sinhala and English. Translations were not literal,
but cross-culturally adapted to Sinhala in wording which
best conveyed the same meaning [46]. Interviews were
conducted in Sinhala or English depending on partici-
pants’ preference.
Anthropometric and blood pressure measurements
Twelve FRAs were trained to collect anthropometric
and blood pressure measurements according to standard
protocols, contemporaneously with the interviews.
Anthropometric measures included standing height, sit-
ting height, weight, waist circumference and were mea-
sured to the closest 0.1 cm/kg. Leg length was estimated
from standing height and sitting height measured using
portable stadiometers (Seca, Germany). BMI was calcu-
lated from standing height and weight using electronic
weighing scales (Seca, Germany). Waist circumference
was measured using measuring tapes. Blood pressure
was measured using Omron HEM-7200 automatic blood
pressure monitors (Omron Healthcare, Japan). Three
blood pressure recordings were obtained from after
10 min of rest with 2–3 min intervals between measure-
ments. Quality checks were done by random spot check-
ing, and by the data entry team.
Biosample collection
Fasting blood and first morning urine samples were
collected during early morning visits to participants’
homes, at the IRD, or specified laboratories. Blood sam-
ples were collected using evacuated blood collection
tubes (Becton Dickinson, USA). From blood samples
the following clinical measures were extracted: fasting
blood glucose, HbA1C (high-performance liquid chro-
matography method), lipid profile, serum glutamic oxa-
loacetic transaminase (SGOT), serum insulin levels,
serum creatinine, and highly sensitive C-reactive pro-
tein. Separate blood samples were collected for extract-
ing DNA and serum separation to be stored in a
biobank for future genetic analyses. Urine samples
provided measures of urine creatinine, urine microalbu-
min, and urine microalbumin-to-creatinine ratio.
Derived measures of metabolic syndrome
We used the most frequently applied metS definitions:
the International Federation of Diabetes (IDF) criteria
[47], and the revised National Cholesterol Education
Programme Adult Treatment Panel (NCEP ATP III) cri-
teria [48]. The revised NCEP ATP III and the IDF cri-
teria share the same components and cut-offs, but are
combined differently to indicate metS. These compo-
nents include: (1) central obesity (waist circumference:
≥90 cm in men, ≥80 cm in women; South Asian
population-specific); (2) raised triglycerides (≥1.7 mmol/
l); (3) reduced HDL-cholesterol (<1.03 mmol/l in men,
<1.29 mmol/l in women); (4) raised blood pressure (sys-
tolic ≥130 mmHg, or diastolic ≥85 mmHg, or hyperten-
sive treatment or previously diagnosed hypertension);
and (5) raised fasting plasma glucose (≥5.6 mmol/l or
previously diagnosed type 2 diabetes). The IDF criteria
defines metS as central obesity in combination with any
two of the other four components. The revised NCEP
ATP III criteria accept the presence of any three compo-
nents to indicate metS, without considering any compo-
nent essential.
Statistical analyses
Percentage prevalence estimates described the sociode-
mographic and socioeconomic characteristics of the full
sample and for twin and singletons separately. To exam-
ine possible attritional bias, we used COTASS-1 data to
describe differences between participants who were in
both study waves, and those who only part-took in
COTASS-1. Chi-square tests and t-tests tested distribu-
tion differences, and logistic regression controlled for
potential confounding factors. Analyses were conducted
in Stata 14 [49] and SPSS 13 [25]. Interferential statistics
accounted for clustering by twins using the ‘svy’ com-
mand in Stata.
The prevalence of cardiometabolic risk indicators and
mental disorders were estimated and stratified by twin/
singleton status, as preliminary analysis indicated that
they differed on key demographic variables. Psychiatric
disorders included depressive disorder (CIDI), depressive
symptoms (BDI-II 16-point cut-off [50]), generalised
anxiety disorder (GAD-7 10-point cut-off ), hazardous al-
cohol use (AUDIT 8-point cut-off ), and post-traumatic
stress disorder (PTSD; PCL-C coded according to DSM
criteria). Cardiometabolic risk indicators included metS
and all its component parts, and a binary BMI measure
applying a South Asian specific cut-off of 23 kg/m2 [51].
MetS was only estimated for respondents with complete
data for all components. Cross-tabulations described the
prevalence distributions of psychiatric disorders and
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cardiometabolic risk indicators by gender, education,
and age groups of 19–34, 35–54, 55+. Separate logistic
regression models tested associations with these demo-
graphic characteristics, whilst adjusting for gender, edu-
cation, age (continuous measure when used as
covariate), marital status, ethnicity and financial strain.
Results
Recruitment
The recruitment process is outlined in Fig. 1. We
attempted to trace 5809 of 6043 COTASS-1 participants,
and successfully traced 5032. Seven hundred seventy-
seven could not be traced, and 603 of the traced
Fig. 1 Flowchart of recruitment
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participants were ineligible. Of the 4429 eligible partici-
pants, 446 refused to participate and 14 were excluded
due to poor data quality. Thus, the final COTASS-2
sample consisted of 3969 participants who completed at
least one study component. Ninety-three participants
from the final COTASS-2 sample had been excluded
from COTASS-1 due to poor data quality, or because
they were younger than 16 at the time. Thus, the cohort
size was 3876. The overall participation rate in
COTASS-2 was 76.4, and 83.4% for twins and 61.8% for
singletons. These participation rates excluded from the
denominator COTASS-1 participants where recruitment
was not attempted, those who were ineligible, and par-
ticipants with poor quality data. Further excluding those
not possible to trace produced an overall response rate
of 89.9% (91.9% for twins, 84.6% for singletons). Detailed
participation rates for each study component are pre-
sented as Additional file 1: Table S2. Participation rates
were high, including 64.7% providing consent for their
DNA to be stored for future genetic research.
Sample characteristics
The COTASS-2 sample consisted of 73.4% (n = 2934)
twins and 26.1% (n = 1035) singletons (Table 1). 57.6%
were female, and ages ranged from 19 to 91 years, with a
mean age of 42.8 years. The majority of the sample were
married and lived in urban areas. The dominant ethnic
group was Sinhalese (92.7%), and Buddhism was the
most commonly reported religion (86.5%). Over half of
the sample were in employment, and of those in employ-
ment, the most frequently reported occupation type was
non-manual or skilled manual labour. Most COTASS-2
participants were educated beyond Grade 6, and 5%
reported university education. Approximately 10%
reported that making ends meet financially was “diffi-
cult” or “very difficult”, 3.9% reported hunger in the past
3 months because of insufficient money to buy food.
Twins and singletons differed on several socio-
demographic and socio-economic characteristics
(Table 2). Notably, singletons were older and a higher
proportion were women, married or widowed, Colombo
residents, of Sinhalese ethnicity and of Buddhist reli-
gious affiliation. Singletons had lower socio-economic
status: they were less likely to be employed or in man-
agerial/professional occupational positions, reported
lower education, and greater financial strain. Post-hoc
analyses tested socio-demographic differences between
twins and singletons, by including age, gender, marital
status, and ethnicity simultaneously in a logistic regres-
sion model (religion substantially overlapped with ethni-
city and was excluded to avoid collinearity; analyses not
shown). These variables were found to independently
distinguish twins from singletons. Further post-hoc re-
gression tests indicated that differences in employment,
occupation and education differences were driven by
age. However, singletons remained at greater risk of
reporting making ends meet “difficult” (p = 0.035), and
hunger due to insufficient money (p < 0.001). Zygosity
characteristics presented in Table 2 are in line with the
usual distribution seen in population studies: slightly
more MZ pairs and slightly more female participants,
with opposite sex pairs being the biggest group.
Systematic differences due to loss to follow-up
Compared to those lost to follow-up (n = 2059), a greater
proportion of the followed-up participants in COTASS-2
(n = 3876) were twins, female, of younger age, of
Sinhalese ethnicity, and residing in semi-urban areas.
Those who were followed-up also had slightly poorer
self-rated health; post-hoc analyses indicated that gender
drove this association, as more women reported fair or
poor health (not shown). There were no attritional dif-
ferences according to marital status, socio-economic sta-
tus or depression (Table 3).
Prevalence and distribution of mental disorders
Table 4 presents prevalence estimates of mental disorder
and associations with demographic characteristics, sep-
arately by twin and singleton status. Informed by the dif-
ferences observed Table 1, associations adjusted for age,
sex, education marital status and financial strain. Twins
and singletons reported similar levels of depressive dis-
order and PTSD. Just under 4% of twins and singletons
met the DSM-IV criteria for major depressive episode in
the past year using the CIDI, and approximately 5%
reported met the DSM criteria for PTDS. Hazardous
alcohol use was highly prevalent in male twins and sin-
gletons (28.1 and 30.9%, respectively). Twins had lower
estimates depressive and anxiety symptoms compared to
singletons (5.9% vs. 9.8%, and 3.6% vs. 5.1%, respect-
ively). Twins and singletons’ mean scores of depressive
symptoms and anxiety symptoms were, respectively, 4.4
and 6.0 on the BDI-II, and 1.7 and 2.2 on the GAD-7
(not shown).
The socio-demographic distributions of mental disor-
ders followed similar patterns in twins and singletons.
Mental disorders were more generally more common in
women, and among those with lower educational attain-
ment. Regression analyses controlling for demographic
characteristics indicated few statistically significant dif-
ferences. These included gender differences for depres-
sive and anxiety symptoms in twins, and educational
differences in hazardous alcohol use in twins and single-
tons, and depressive symptoms and PTSD in twins.
Depressive disorder and PTSD was less common in the
older age group (55+) compared to those aged 19–34.
Depressive symptoms and anxiety symptoms did not
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Table 1 Demographic and socio-economic characteristics of the COTASS-2 sample
Total sample
N = 3969
Twins
N = 2934
Singletons
N = 1035
Twins vs Singletonsa
%/mean (n) %/mean (n) %/mean (n) Χ2/t-test
p-value
Gender 0.001
Male 42.4 (1681) 43.9 (1289) 37.9 (392)
Female 57.6 (2288) 56.1 (1645) 62.1 (643)
Mean age 42.8 (3969) 39.9 (2934) 51.2 (1035) <0.001
Age categories <0.001
19–29 21.6 (865) 26.3 (772) 8.3 (86)
30–39 25.8 (1025) 29.0 (852) 16.7 (173)
40–49 21.0 (835) 20.7 (607) 22.0 (228)
50–59 16.8 (667) 15.3 (449) 21.1 (218)
60–69 9.6 (380) 5.9 (173) 20.0 (207)
70+ 5.1 (204) 2.8 (81) 11.9 (123)
Marital status <0.001
Married 72.2 (2838) 70.7 (2048) 76.5 (790)
Widowed 6.3 (246) 3.8 (111) 13.1 (135)
Divorced/Separated 2.1 (83) 1.8 (53) 2.9 (30)
Never married 19.4 (763) 23.6 (685) 7.6 (78)
Ethnicity <0.001
Sinhala 92.7 (3647) 91.6 (2656) 95.7 (991)
Tamil 3.1 (120) 3.5 (101) 1.8 (19)
Muslim 3.8 (150) 4.5 (130) 1.9 (20)
Other 0.4 (16) 0.4 (11) 0.5 (5)
Religion <0.001
Buddhist 86.5 (3401) 85.4 (2475) 89.5 (926)
Hindu 1.6 (64) 2.0 (57) 0.7 (7)
Islam 4.0 (159) 4.7 (137) 2.1 (22)
Christian 7.9 (309) 7.9 (229) 7.7 (80)
Urbanicity <0.001
Urban 60.2 (2390) 59.9 (1758) 61.1 (632)
Rural 13.4 (533) 13.0 (380) 14.8 (153)
Mixed 20.8 (826) 19.9 (585) 23.3 (241)
Outside Colombo 5.6 (221) 7.2 (212) 0.9 (9)
Employment <0.001
Employed 56.1 (2206) 59.6 (1727) 46.3 (479)
At home 40.8 (1605) 36.9 (1070) 51.7 (535)
Student 1.2 (48) 1.6 (46) 0.2 (2)
Unemployed off sick 1.3 (52) 1.2 (35) 1.6 (17)
Other 0.6 (23) 0.7 (21) 0.2 (2)
Social class <0.001
Managers/Professionals 8.1 (318) 9.3 (267) 4.9 (51)
Non-manual workers/ Skilled manual workers 39.5 (1540) 41.7 (1197) 33.2 (343)
Elementary occupations 8.3 (322) 8.3 (239) 8.0 (83)
Not in employment 44.1 (1723) 40.7 (1167) 53.8 (556)
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vary by age, while hazardous alcohol use peaked in men
aged 35–54 years.
Prevalence and distribution of metabolic syndrome
Table 5 presents prevalence distributions of cardiometa-
bolic risk factors, and adjusted associations with demo-
graphic characteristics for twins and singletons. A third
of the twin sample and nearly half of the singletons met
the metS criteria (Table 5). The prevalence was slightly
higher according to the NCEP ATP III definition in both
samples. There were substantial differences in metS by
gender. Approximately 34% of female twins, and 55% of
female singletons met the metS criteria; whereas 26 and
36% of men in the respective samples met these criteria.
These differences were driven by a high proportion of
women meeting the gender-specific criteria for central
obesity: over 78% of female twins and singletons had
waist circumferences ≥80 cm while only 35% of male
twins and 42% of male singletons were above the
≥90 cm threshold. This put female twins and singletons
at 7- and 12-fold increased odds of central obesity, re-
spectively. In comparison, the gender differences in the
BMI indicator of overweight by were not as pronounced
(AORs ≥ 2.1; Table 5). The prevalence of individual metS
components ranged from 25 to 59% in twins and 30–
71% in singletons. Aside from waist circumference,
raised fasting glucose or diabetes was the most common
metS component, with 38% of twins and 58% of single-
tons above the threshold. Raised triglyceride levels was
the least common component in both samples, but still
over a quarter of twins and singletons were at elevated
risk. In both samples, women were at three times’ in-
creased odds of reduced HDL-cholesterol, while men
were at greater odds of raised triglyceride levels. The
blood pressure component and raised fasting glucose or
diabetes component did not vary by gender. There were
few cardiometabolic risk differences by education; only
BMI and waist circumference was lower among those
with lower education (differences were statistically sig-
nificant in twins, and marginally significant in
Table 1 Demographic and socio-economic characteristics of the COTASS-2 sample (Continued)
Total sample
N = 3969
Twins
N = 2934
Singletons
N = 1035
Twins vs Singletonsa
%/mean (n) %/mean (n) %/mean (n) Χ2/t-test
p-value
Education 0.002
No education 1.8 (321) 1.8 (52) 1.6 (16)
Grade 1–5 9.0 (2389) 9.2 (264) 8.6 (87)
Grade 6-o/ls 42.9 (929) 40.9 (1174) 48.7 (490)
Passed o/ls 18.5 (276) 18.8 (541) 17.6 (177)
A/ls 22.3 (865) 23.3 (669) 19.5 (196)
University or higher 5.0 (193) 5.4 (156) 3.7 (37)
Other 0.5 (20) 0.6 (17) 0.3 (3)
Financial strain <0.001
Living comfortably 9.3 (365) 9.4 (273) 8.9 (92)
Doing alright 66.5 (2616) 68.3 (1979) 61.5 (637)
Just about getting by 13.9 (547) 13.4 (388) 15.4 (159)
Difficult to make ends meet 7.2 (284) 6.3 (182) 9.9 (102)
Very difficult to make ends meet 3.1 (121) 2.6 (76) 4.3 (45)
Hungry due to lack of money <0.001
No 96.1 (3779) 97.2 (2815) 93.1 (964)
Yes 3.9 (153) 2.8 (82) 6.9 (71)
Due to incomplete questionnaire data, the numbers do not add up to totals presented beyond gender and age
aAnalyses account for clustering by twins
Table 2 Twins participating in COTASS-2
Zygosity Number of
Individual
Number of
Twin Families
Monozygotic Males (MZM) 533 295
Dizygotic Males (DZM) 366 215
Monozygotic Females (MZF) 730 397
Dizygotic females (DZF) 485 281
Dizygotic Opposite Sex (DZOS) 809 467
Triplets 11 5
Zygosity missing 1 –
Number of individuals in the twin groups is not twice the number of families
due to missing data. Actual numbers of ‘complete pairs’ are not given since
those differ per variable
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singletons). MetS components were more common in
the older age groups, and those aged 55+ were at par-
ticularly elevated odds of raised blood pressure (AOR ≥
10.5) and raised fasting glucose or diabetes (AOR ≥ 2.8),
compared to those aged 19–34. Age distributions of car-
diometabolic risk were similar between twins and single-
tons, with the exception of central obesity and BMI.
These indicated that younger (19–34) and middle-age
(35–54) singletons had higher BMI and waist circumfer-
ence than equivalent age groups in twins, whilst preva-
lence estimates in the 55+ age groups were comparable.
Discussion
COTASS-2 is a well-phenotyped, genetically-sensitive,
epidemiological sample within a middle income country
setting. As such it provides a unique resource to explore
the associations between the underlying constituents of
metS and wider risk factors for CVD and diabetes and
mental disorders. It also provides a basis for a better
Table 3 Characteristics of respondents not followed-up and
followed-up in COTASS-2, using data from COTASS-1
Lost to follow up
(COTASS 1 only,
N = 2059)
Followed-up
(COTASS1 + 2,
N = 3876)a
Lost to follow-up
VS followed upb
% /mean (n) % /mean (n) p-value
Χ2 / t-test
Twin or singleton <0.001
Twin 52.4 (1078) 73.5 (2849)
Singleton 47.6 (981) 26.5 (1027)
Gender <0.001
Male 52.5 (1082) 42.1 (1633)
Female 47.5 (977) 57.9 (2243)
Mean age (years) 38.0 (2055) 36.7 (3876) <0.001
Age (years) <0.001
16–24 25.1 (515) 23.7 (918)
25–34 24.0 (494) 26.4 (1024)
35–44 18.4 (379) 20.6 (798)
45–54 15.0 (308) 16.2 (627)
55–64 10.0 (205) 9.0 (349)
65–74 5.3 (109) 3.5 (136)
75 or over 2.2 (45) 0.6 (24)
Marital status 0.114
Married 58.0 (1194) 61.4 (2378)
Widowed 5.1 (105) 4.8 (185)
Divorced/
Separated
1.6 (32) 1.4 (53)
Never married 35.3 (727) 32.4 (1255)
Ethnicity 0.001
Sinhala 90.4 (1862) 93.4 (3619)
Tamil 3.1 (63) 2.6 (102)
Muslim 6.1 (126) 3.7 (145)
Other 0.4 (8) 0.3 (10)
Urbanicity <0.001
Semi-urban 56.8 (1170) 62.9 (2436)
Urban 43.2 (889) 37.1 (1438)
Employment 0.118
Not in
employment
39.4 (809) 41.8 (1617)
Student 8.2 (169) 8.0 (308)
Part-time
employment
13.0 (267) 14.2 (549)
Full-time
employment
39.3 (806) 36.1 (1396)
Social class 0.079
Rich 30.5 (252) 25.9 (385)
Middle class 33.3 (276) 34.9 (518)
Poor 36.2 (299) 39.2 (583)
Table 3 Characteristics of respondents not followed-up and
followed-up in COTASS-2, using data from COTASS-1 (Continued)
Lost to follow up
(COTASS 1 only,
N = 2059)
Followed-up
(COTASS1 + 2,
N = 3876)a
Lost to follow-up
VS followed upb
% /mean (n) % /mean (n) p-value
Χ2 / t-test
Financial strain 0.177
Living
comfortably
8.9 (183) 7.9 (304)
Doing alright 64.1 (1316) 64.7 (2504)
Just about
getting by
13.0 (267) 14.6 (563)
Difficult to make
ends meet
8.9 (182) 8.7 (336)
Very difficult to
make ends meet
5.2 (106) 4.2 (162)
Hungry due to lack
of money
0.653
No 96.3 (1978) 96.0 (3716)
Yes 3.7 (77) 4.0 (155)
Self-rated health 0.032
Good, very
good or
excellent
57.5 (1179) 54.6 (2109)
Fair or poor 42.5 (870) 45.4 (1756)
Depressive
episode (lifetime)c
0.750
No 94.6 (1945) 94.4 (3653)
Yes 5.4 (110) 5.6 (215)
aFollowed-up respondents represent the cohort with data at both COTASS 1
and 2; COTASS 2 respondents which were excluded from COTASS 1 could not
be included in these analyses (n = 93)
bAnalyses account for clustering by twins
cEstimated using the Composite International Diagnostic Interview
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understanding of the inter-relationships between mental
and physical health more broadly.
Prevalence of mental disorders
Our sample had a generally low prevalence of most
mental disorders. 3.8% of twins and 3.9% of singletons
met the criteria for major depressive disorder (DSM-IV),
and 3.6% of twins and 5.1% of singletons reported
moderate or severe anxiety symptoms (GAD-7 ≥ 10).
Whilst the prevalence of major depressive disorder are
in line with previous studies in Colombo (6.4%) and
other South Asian populations (4.5% in India and 4.0%
in Indian minority groups in Singapore [45, 52, 53]),
most international studies report higher estimates (e.g.
8.3% in USA, and 5.5 and 5.9% in high-income countries
and LMIC, respectively [52]). The estimates of anxiety
Table 4 Prevalence and adjusted associations of mental disorders with sociodemographic indicators in twins and singletons
Total
sample
Gender Education Age
Male Female Higher Lower 19–34 35–54 55+
Twins (N = 2934) (n = 1289) (n = 1645) (n = 960) (n = 1923) (n = 1197) (n = 1302) (n = 435)
Depressive disorder (N = 2899)
% (n) 3.8 (110) 3.1 (39) 4.4 (71) 3.6 (35) 3.9 (75) 4.1 (48) 4.0 (52) 2.3 (10)
AOR (95% CI) ref. 1.3 (0.9–2.0) ref. 1.1 (0.7–1.7) ref. 0.9 (0.6–1.4) 0.3* (0.1–0.8)
Depressive symptoms (N = 2883)
% (n) 5.9 (170) 4.1 (52) 7.3 (118) 3.6 (34) 7.1 (136) 5.5 (65) 5.9 (76) 6.8 (29)
AOR (95% CI) ref. 1.7** (1.2–2.5) ref. 2.0** (1.3–3.1) ref. 0.9 (0.6–1.4) 0.8 (0.4–1.4)
Generalised anxiety disorder (N = 2893)
% (n) 3.6 (103) 2.5 (32) 4.4 (71) 2.7 (26) 4.0 (77) 3.6 (42) 3.6 (46) 3.5 (15)
AOR (95% CI) ref. 1.7* (1.1–2.6) ref. 1.5 (0.9–2.6) ref. 0.9 (0.5–1.5) 0.6 (0.3–1.5)
PTSD (N = 2896)
% (n) 4.5 (131) 3.6 (46) 5.2 (85) 2.7 (26) 5.4 (104) 4.1 (49) 5.1 (65) 4.0 (17)
AOR (95% CI) ref. 1.4 (0.9–2.0) ref. 2.1** (1.3–3.4) ref. 1.0 (0.7–1.6) 0.4* (0.4–0.8)
Men only a (N = 1289) – – (n = 400) (n = 861) (n = 557) (n = 562) (n = 170)
Hazardous alcohol use (N = 1658)
% (n) 28.1 (356) – – 18.0 (72) 32.6 (280) 20.9 (115) 36.7 (202) 23.2 (39)
AOR (95% CI) – – ref. 1.9*** (1.4–2.6) ref. 1.7** (1.2–2.4) 1.0 (0.5–1.3)
Singletons (N = 1035) (n = 392) (n = 643) (n = 245) (n = 787) (n = 146) (n = 450) (n = 439)
Depressive disorder (N = 1035)
% (n) 3.9 (40) 2.6 (10) 4.7 (30) 4.9 (12) 3.6 (28) 7.5 (11) 4.0 (18) 2.5 (11)
AOR (95% CI) ref. 1.7 (0.8–3.6) ref. 0.7 (0.4–1.5) ref. 0.5 (0.2–1.1) 0.3** (0.1–0.7)
Depressive symptoms (N = 1030)
% (n) 9.8 (101) 6.7 (26) 11.7 (75) 5.7 (14) 11.0 (86) 6.2 (9) 10.5 (47) 10.3 (45)
AOR (95% CI) ref. 1.6 (0.98–2.6) ref. 1.7 (0.9–3.1) ref. 1.9 (0.8–4.5) 1.6 (0.7–3.6)
Generalised anxiety disorder (N = 1034)
% (n) 5.1 (53) 4.1 (16) 5.8 (37) 2.9 (7) 5.9 (46) 4.8 (7) 6.4 (29) 3.9 (17)
AOR (95% CI) ref. 1.3 (0.7–2.6) ref. 2.3 (0.99–5.3) ref. 1.7 (0.6–4.7) 0.9 (0.3–2.6)
PTSD (N = 1035)
% (n) 5.4 (56) 4.1 (16) 6.2 (40) 4.5 (11) 5.7 (45) 5.5 (8) 7.3 (33) 3.4 (15)
AOR (95% CI) ref. 1.5 (0.8–2.7) ref. 1.3 (0.7–2.7) ref. 1.3 (0.5–3.2) 0.6 (0.2–1.5)
Men only a (n = 392) – – (n = 101) (n = 290) (n = 65) (n = 143) (n = 184)
Hazardous alcohol use (N = 391)
% (n) 30.9 (121) – – 24.0 (24) 33.4 (97) 33.8 (22) 44.8 (64) 19.1 (35)
AOR (95% CI) – – ref. 1.9* (1.1–3.3) ref. 1.9 (0.9–3.9) 0.5 (0.2–1.1)
Odds ratios adjust for age, gender, education, marital status, ethnicity and financial strain
AOR Adjusted odds ratio, CI confidence interval; PTSD Post-Traumatic Stress Disorder, DSM Diagnostic and Statistical Manual of Mental Disorders
p < 0.05, ** p < 0.01, ***p < 0.001 aLimited to men only, due to very low prevalence in female group (0.04%, n = 1); AORs adjusted for education and age only
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Table 5 Prevalence and adjusted associations of cardiometabolic risk indicators with sociodemographic indicators in twins and
singletons
Total
sample
Gender Education Age
Male Female Higher Lower 19–34 35–54 55+
Twins (N = 2934) (n = 1289) (n = 1645) (n = 960) (n = 1923) (n = 1197) (n = 1302) (n = 435)
MetS: IDF (N = 2553)
% (n) 27.4 (700) 19.9 (229) 33.6 (471) 25.0 (200) 28.7 (491) 13.8 (142) 33.7 (388) 45.5 (170)
AOR (95% CI) ref. 2.0*** (1.6–2.4) ref. 0.8 (0.7–1.0) ref. 2.6*** (2.0–3.4) 4.3*** (3.1–5.9)
MetS: NCEP ATP III (N = 2553)
% (n) 30.6 (780) 25.9 (298) 34.4 (482) 27.6 (221) 32.1 (549) 16.1 (166) 37.0 (425) 50.5 (189)
AOR (95% CI) ref. 1.4** (1.2–1.7) ref. 0.8 (0.7–1.0) ref. 2.5*** (1.9–3.1) 4.3*** (3.1–5.8)
BMI ≥23 (N = 2738)
% (n) 52.3 (1431) 45.7 (559) 57.6 (872) 55.2 (487) 50.9 (920) 45.5 (502) 57.3 (703) 55.5 (226)
AOR (95% CI) ref. 1.5*** (1.3–1.8) ref. 0.7*** (0.6–0.8) ref. 1.4** (1.1–1.7) 1.3* (1.0–1.8)
Central obesity (N = 2743)
% (n) 59.2 (1623) 34.8 (425) 78.8 (1198) 62.9 (555) 57.7 (1045) 48.4 (535) 65.9 (810) 68.0 (278)
AOR (95% CI) ref. 7.4*** (6.0–9.0) ref. 0.5*** (0.4–0.7) ref. 1.8*** (1.4–2.3) 2.0*** (1.5–2.8)
Raised triglycerides (N = 2577)
% (n) 25.0 (644) 35.6 (413) 16.3 (231) 24.4 (197) 25.5 (439) 21.1 (220) 28.6 (331) 24.7 (93)
AOR (95% CI) ref. 0.3*** (0.3–0.4) ref. 0.9 (0.7–1.1) ref. 1.5** (1.2–1.9) 1.4 (0.8–1.6)
Low HDL cholesterol (N = 2577)
% (n) 32.3 (832) 20.2 (234) 42.2 (598) 30.8 (249) 33.0 (569) 34.7 (362) 31.5 (364) 28.2 (106)
AOR (95% CI) ref. 2.9*** (2.4–3.5) ref. 1.2 (0.9–1.5) ref. 0.7** (0.5–0.8) 0.5*** (0.4–0.8)
Raised BP /hypertensive tx (N = 2747)
% (n) 27.4 (754) 28.0 (343) 27.0 (411) 19.9 (176) 31.2 (565) 11.4 (126) 30.3 (373) 62.2 (255)
AOR (95% CI) ref. 0.8 (0.7–1.0) ref. 1.1 (0.9–1.4) ref. 3.0*** (2.3–3.9) 10.5***(7.6–14.5)
Raised fasting glucose/diabetes (N = 2597)
% (n) 38.2 (992) 38.1 (444) 38.3 (548) 34.1 (279) 40.1 (695) 20.3 (212) 46.4 (541) 61.8 (239)
AOR (95% CI) ref. 0.9 (0.8–1.1) ref. 0.9 (0.7–1.1) ref. 3.0*** (2.4–3.7) 5.9*** (4.4–7.8)
Singletons (N = 1035) (n = 392) (n = 643) (n = 245) (n = 787) (n = 146) (n = 450) (n = 439)
MetS: IDF (N = 891)
% (n) 44.6 (397) 28.3 (98) 54.9 (299) 41.2 (89) 45.4 (305) 27.9 (34) 43.1 (175) 51.8 (188)
AOR (95% CI) ref. 3.5*** (2.5–4.8) ref. 1.0 (0.7–1.4) ref. 1.6 (1.0–2.5) 2.6*** (1.6–4.3)
MetS: NCEP ATP III (N = 891)
% (n) 48.6 (433) 36.4 (126) 56.3 (307) 45.8 (99) 49.3 (331) 29.5 (36) 46.3 (188) 57.6 (209)
AOR (95% CI) ref. 2.6*** (1.9–3.6) ref. 1.0 (0.7–1.4) ref. 1.7* (1.0–2.7) 3.0*** (1.9–4.9)
BMI ≥23 (N = 925)
% (n) 61.0 (564) 49.7 (177) 68.0 (387) 65.0 (147) 59.6 (415) 63.0 (80) 68.1 (282) 52.6 (202)
AOR (95% CI) ref. 2.1*** (1.6–2.8) ref. 0.8 (0.6–1.1) ref. 1.0 (0.6–1.5) 0.6* (0.4–0.9)
Central obesity (N = 926)
% (n) 71.2 (659) 41.7 (149) 89.6 (510) 72.1 (163) 70.7 (493) 63.8 (81) 75.4 (313) 69.0 (265)
AOR (95% CI) ref. 12.4*** (8.6–18.0) ref. 0.7 (0.5–1.1) ref. 1.1 (0.6–1.9) 1.0 (0.6–1.7)
Raised triglycerides (N = 899)
% (n) 29.6 (266) 37.2 (130) 24.7 (136) 32.7 (71) 28.7 (195) 31.5 (39) 31.0 (127) 27.4 (100)
AOR (95% CI) ref. 0.6*** (0.4–0.8) ref. 0.8 (0.6–1.1) ref. 1.0 (0.6–1.6) 0.8 (0.6–1.2)
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symptoms were low within an international context (e.g.
8.2% (GAD-7 ≥ 8) in North America, 5.1% (GAD-7 ≥ 10)
in Europe, and 11.2% (GAD-7 ≥ 10) in Pakistan [54]). In
contrast, the prevalence of PTSD symptoms of 4.5% in
twins and 5.4% in singletons was broadly consistent with
international research (3.5% in USA [55], 5.5% in UK
[56]). Virtually no women reported hazardous alcohol
use, while approximately one third of men were hazard-
ous drinkers. The prevalence is high compared to Asian
groups in the UK [57], and is consistent with alcohol use
being recognised as an increasingly common problem in
Sri Lanka [58].
Prevalence of metabolic syndrome and its constituent
components
By contrast with mental disorders, we report a very
high prevalence of metS (IDF: 27.4% in twins, 44.6% in
singletons; NCEP ATP III: 30.6% in twins, 48.6% in
singletons). These findings are consistent with
previously observed estimates in urban areas of Sri
Lanka (IDF: 34.8% [59]; IDF: 38.9%, revised NCEP ATP
III: 46.1% in adults aged 35–65 [60]). Gender-specific
prevalence estimates are also comparable to those
found in the Sri Lankan population (COTASS-2: 19.9–
28.3% and 33.6–54.9%; Sri Lanka Diabetes and Cardio-
vascular Study: 24.3 and 40.8%; in men and women,
respectively [59]). This suggests that future analyses of
this sample are likely to be broadly generalisable for Sri
Lanka. More broadly, urban household studies in South
Asia typically find prevalence estimates that are com-
parable to the singleton estimates in COTASS-2, both
according to IDF criteria (35% in Pakistan) [61], and
various versions of the NCEP ATP III criteria (41–49%
in India and Pakistan) [61–63]. In wider international
comparisons, the COTASS-2 estimates are in line with
the US general population (NCEP ATP III: 33% [64]),
South Asian immigrant adults in the US (IDF: 29.7%
[65]; IDF: 38.2%, revised NCEP ATP III: 32.7% [66]),
and men of South Asian ethnicity aged 40–69 in the
UK (IDF: 44.5%) [67].
The prevalence of metS increased with age, consist-
ent with the literature [59, 60, 64, 68], but few differ-
ences were observed by levels of education. While US
and other Western studies indicate higher prevalence
of metS in groups with low education, the Sri Lanka
Diabetes and Cardiovascular Study, carried out in
2005–2006, found that higher education groups were
more likely to meet the criteria for metS [59, 69].
Given that the association between metS and socio-
economic status seems to be heavily influenced by
health behaviours [70], the findings from our more
recent study may indicate a shift of socioeconomic
distributions of health behaviours in Sri Lanka
towards those observed in Western populations.
The gender-specific distributions of metS components
were broadly consistent with previous research [9, 60, 66,
71, 72]. Women were more likely to have low HDL chol-
esterol and higher waist circumference, while men more
likely to have raised triglyceride levels, and there were no
differences in hypertension or raised blood glucose levels.
The most common metS components were central obesity
and raised fasting blood glucose or diabetes. Central obes-
ity was a more prominent feature compared to other Sri
Lankan studies where the most prevalent components
were hypertension [59] and fasting blood glucose [60].
The variability of individual metS components within Sri
Lanka may be indicative of a lack of consistent clustering
of metS components in the population.
The high estimates of central obesity are consistent with
the increasing prevalence of obesity in Sri Lanka which has
Table 5 Prevalence and adjusted associations of cardiometabolic risk indicators with sociodemographic indicators in twins and
singletons (Continued)
Total
sample
Gender Education Age
Male Female Higher Lower 19–34 35–54 55+
Low HDL cholesterol (N = 899)
% (n) 39.9 (359) 24.9 (87) 49.5 (272) 39.2 (85) 39.9 (271) 38.7 (48) 44.6 (183) 35.1 (128)
AOR (95% CI) ref. 2.9*** (2.2–4.0) ref. 1.0 (0.7–1.4) ref. 1.1 (0.7–1.8) 0.8 (0.5–1.3)
Raised BP /hypertensive tx (N = 928)
% (n) 46.6 (432) 48.7 (175) 45.2 (257) 40.7 (92) 48.5 (339) 12.5 (16) 33.0 (137) 72.5 (279)
AOR (95% CI) ref. 0.9 (0.7–1.3) ref. 1.0 (0.7–1.4) ref. 3.3*** (1.8–6.1) 16.6***(8.9–30.9)
Raised fasting glucose/diabetes (N = 923)
% (n) 56.7 (523) 54.9 (196) 57.8 (327) 52.3 (115) 57.9 (405) 39.5 (49) 51.2 (212) 68.1 (262)
AOR (95% CI) ref. 1.3 (0.97–1.7) ref. 1.2 (0.8–1.6) ref. 1.2 (0.8–1.9) 2.8*** (1.8–4.4)
Odds ratios adjust for age, gender, education, marital status, ethnicity and financial strain
AOR Adjusted odds ratio, CI confidence interval, MetS metabolic syndrome, IDF International Diabetes Federation criteria, NCEP ATP III revised National Cholesterol
Education Programme Adult Treatment Panel criteria, BMI Body-Mass Index, BP blood pressure
* p < 0.05, ** p < 0.01, ***p < 0.001
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been described as reaching epidemic proportions [10, 72].
Central obesity was particularly prevalent among women,
and this gender discrepancy was much greater than the dif-
ferences in overweight defined by BMI. However, the very
high prevalence of central obesity (78.8% in female twins;
89.6% in female singletons) was not consistent with the
prevalence of other metS components (<60%). This may
suggest that the 80 cm cut-off of waist circumference over-
estimates cardiometabolic risk for Sri Lankan women. The
observation that twins were less likely than singletons to be
overweight, particularly in younger age groups, could be an
effect of twins’ lower birth weight, affecting weight in
adulthood [73].
Raised blood glucose levels were alarmingly high at
38.2% of twins and 56.7% of singletons. This was consid-
erably higher than observed in studies in the US and
India [74, 75], and substantially higher than previously
observed rates of dysglycaemia in urban areas of the Sri
Lanka (30.0%) [7]. The prevalence was particularly high
among older adults, but also elevated in younger adults.
These findings re-affirm concerns of a diabetes epidemic
in Sri Lanka [76].
Limitations
Our original sample had an exceptionally high participa-
tion rate (91% for twins and 87% for singletons). The
present study achieved good follow up rates, particularly
for twins (83.4%), where participants usually had contact
details for their co-twins. There is always a risk of bias
caused by non-participation, which is particularly
important for mental disorders, which have a critical
impact on participation [77]. However, unlike many sur-
veys we did not find that depression influenced partici-
pation, suggesting that attrition will have minimal
influence on analyses examining mental health out-
comes. Furthermore, given that neither depression nor
self-rated health determined follow-up, it is unlikely that
loss to follow-up will influence the findings. As this sam-
ple had completed a psychiatric interview during the
previous wave of data collection (COTASS-1), it is pos-
sible that individuals identified as having a mental dis-
order followed our advice to seek treatment, which
caused a reduction in prevalence of mental disorders in
COTASS-2. However, given that this was merely a
recommendation rather than a formal intervention, it is
unlikely that a high proportion advised to consult did so.
We therefore believe that this did not have a major
impact on prevalence. Furthermore, the lifetime depres-
sive disorder outcome captured by the CIDI will not
have been affected by ascertaining mental disorder at a
previous timepoint.
It is possible that twins differ from non-twins in ways
that affect health and limit the interpretation of our
prevalence estimates. Our analyses presented the results
by twins and singletons, and showed some modest dif-
ferences in mental health, whilst, singletons were at
greater cardiometabolic risk compared to twins. Twins
and singletons’ sociodemographic distributions of mental
disorders and cardiometabolic risk were similar.
In terms of data collection, due to the multicompo-
nent nature of the study with separate specialist data
collection teams, it was not always possible to collect
data from all components simultaneously for each par-
ticipant. In addition, biospecimens were collected early
in the morning whereas questionnaire data and
anthropometric measurements could be collected at any
time during the day when participants were available.
Conclusions
We successfully followed up the previous cohort of
twins and singletons. The initial findings indicate that an
exceptionally high proportion of the singleton popula-
tion we studied have metS – a finding of profound im-
portance for public health planning, which suggests that
over the next decades its impact will be felt in terms of
increasing prevalence of diabetes and cardiovascular dis-
ease. Our findings indicate the need for population level
preventive approaches particularly targeting diet and
exercise. Future papers will describe in greater depth the
association between metS variables, their genetic archi-
tecture and association with mental health.
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